Image courtesy of Jacobs

A biomanufacturing facility is a San Francisco developer’s choice for the last available parcel at Andover’s Minuteman Office Park.

Sear Street Capital proposes a 224,500-square-foot cGMP facility including office space and labs at 300 Minuteman Road.

The sought-after suburban life science use would replace an office building approved for the parcel in 2004 that was never built because of market conditions, according to a submission to the Andover planning board.

“cGMP facilities are in increasing demand as the current pandemic and increasing tensions with competitors and adversaries abroad has steeped the public demand for keeping more of our drug development and manufacturing here in the United States,” the special permit application stated.

Developers noted that the town of Andover’s zoning bylaws don’t have specific parking requirements for biomanufacturing, but the use tends to generate less parking demand than office buildings and more than typical process manufacturing. Unlike traditional drug manufacturing facilities, cGMP properties include lab functions that are used to evaluate production processes.

Spear Street Capital bought the property in September 2015 for $9.5 million.

More life science development could be coming to Minuteman Park following the acquisition of another commercial site by the nation’s largest life science developer.

Alexandria Real Estate Equities paid $32 million in September for 3000 Minuteman Road, a 109-acre parcel that contains a single 88,000-square-foot office building being vacated by Philips Healthcare for its move to Cambridge Crossing.

Suburban office parks are among the top choices for biomanufacturing growth in the Greater Boston market. Burlington-based Nordblom Co. recently received approval for a 270,000-square-foot drug manufacturing facility at 25 Network Drive in Northwest Park, while HYM Investment Group plans a 500,000-square-foot lab and biomanufacturing building in Revere as the first phase of the Suffolk Downs redevelopment.

And in July, Cambridge-based Generation Bio leased 104,000 square feet at 41 Seyon St. in Waltham for a new $45-million biomanufacturing facility.